biote (NASDAQ:BTMD – Get Rating) and Akanda (NASDAQ:AKAN – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends.
Profitability
This table compares biote and Akanda's net margins, return on equity and return on assets.
Get
biote alerts:
| Net Margins | Return on Equity | Return on Assets |
| biote | N/A | -20.05% | 5.99% |
| Akanda | N/A | N/A | N/A |
Earnings & Valuation
This table compares biote and Akanda's revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
| biote | N/A | N/A | $11.11 million | N/A | N/A |
| Akanda | $40,000.00 | 107.69 | -$8.13 million | N/A | N/A |
biote has higher earnings, but lower revenue than Akanda.
Institutional and Insider Ownership
3.8% of biote shares are held by institutional investors. Comparatively, 0.4% of Akanda shares are held by institutional investors. 20.0% of biote shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a summary of recent ratings and price targets for biote and Akanda, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
| biote | 0 | 0 | 4 | 0 | 3.00 |
| Akanda | 0 | 0 | 0 | 0 | N/A |
biote currently has a consensus price target of $10.25, indicating a potential upside of 174.80%. Given biote's higher possible upside, equities research analysts plainly believe biote is more favorable than Akanda.
Summary
biote beats Akanda on 6 of the 8 factors compared between the two stocks.
About biote
(Get Rating)
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
About Akanda
(Get Rating)
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Receive News & Ratings for biote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for biote and related companies with MarketBeat.com's FREE daily email newsletter.
